Asthma is a chronic disease involving the airways in the lungs. These airways, or bronchial tubes, allow air to come in and out of the lungs. For many asthma sufferers, the timing of these symptoms is closely related to physical activity and some otherwise healthy people can develop asthma symptoms only when exercising. People with a family history of allergies or asthma are more prone to developing asthma. Many people with asthma also have allergies. This is called allergic asthma.

The global asthma therapeutics market accounted for USD 20.7 billion as of 2015 and is anticipated to exhibit a sluggish growth rate of 2.2% over the forecast period. This is attributed to the generic erosion faced by leading brands. On the other hand, increasing incidences of respiratory diseases coupled with the demand for cost-effective treatment options is expected to drive the asthma therapeutics market growth during the forecast period from 2016 to 2024.